SMARCB1 and thyroid gland papillary carcinoma: In agreement with prior observations, we found that follicular cancer tended to have a higher frequency of loss of INI1 expression (p = 0.073) in the present study, and the follicular variant of papillary thyroid cancer was significantly associated with SMARCB1 underexpression in the TCGA dataset.